GOKINFA Trademark

Trademark Overview

On Monday, March 21, 2022, a trademark application was filed for GOKINFA with the United States Patent and Trademark Office. The USPTO has given the GOKINFA trademark a serial number of 97322569. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Wednesday, August 21, 2024. This trademark is owned by PTC Therapeutics, Inc.. The GOKINFA trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of genetic diseases and disorders
gokinfa

General Information

Serial Number97322569
Word MarkGOKINFA
Filing DateMonday, March 21, 2022
Status733 - FOURTH EXTENSION - GRANTED
Status DateWednesday, August 21, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 19, 2022

Trademark Statements

Goods and Servicespharmaceutical preparations for the treatment of genetic diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 28, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePTC Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth Plainfield, NJ 07080
Party NamePTC Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth Plainfield, NJ 07080

Trademark Events

Event DateEvent Description
Thursday, March 24, 2022NEW APPLICATION ENTERED
Monday, March 28, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, June 8, 2022ASSIGNED TO EXAMINER
Monday, June 13, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 29, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 19, 2022PUBLISHED FOR OPPOSITION
Tuesday, July 19, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 13, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, January 26, 2023SOU TEAS EXTENSION RECEIVED
Thursday, January 26, 2023SOU EXTENSION 1 FILED
Thursday, January 26, 2023SOU EXTENSION 1 GRANTED
Saturday, January 28, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 9, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, June 9, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 9, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 15, 2023SOU EXTENSION 2 FILED
Tuesday, August 15, 2023SOU EXTENSION 2 GRANTED
Monday, March 11, 2024SOU EXTENSION 3 GRANTED
Monday, July 3, 2023ASSIGNED TO EXAMINER
Tuesday, August 15, 2023SOU TEAS EXTENSION RECEIVED
Thursday, August 17, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 11, 2024SOU TEAS EXTENSION RECEIVED
Monday, March 11, 2024SOU EXTENSION 3 FILED
Friday, April 19, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 12, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 19, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, April 19, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, April 19, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 19, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 29, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 29, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 29, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 21, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, August 21, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 21, 2024SOU EXTENSION 4 FILED
Wednesday, August 21, 2024SOU EXTENSION 4 GRANTED

Related Keywords

gokinfa diseases disorders genetic treatment preparations pharmaceutical